RETINAL DYSTROPHIES
Clinical trials for RETINAL DYSTROPHIES explained in plain language.
Never miss a new study
Get alerted when new RETINAL DYSTROPHIES trials appear
Sign up with your email to follow new studies for RETINAL DYSTROPHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental eye drug shows promise for rare Blindness-Causing disease
Disease control OngoingThis study tests an experimental drug called VP-001 for people with a rare genetic eye disease that causes vision loss. The drug is injected into the eye and aims to slow or stop further damage. Researchers will check safety and measure any changes in eyesight over about two year…
Matched conditions: RETINAL DYSTROPHIES
Phase: PHASE1, PHASE2 • Sponsor: PYC Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Sound-Guided gaze: new device aims to sharpen eye imaging for the visually impaired
Symptom relief ENROLLING_BY_INVITATIONThis study tests a device that uses real-time sound feedback to help people with vision loss fix their gaze on a target. Participants hear sounds that guide their eyes back to center when they drift. The goal is to improve the quality of eye imaging by reducing blur from eye move…
Matched conditions: RETINAL DYSTROPHIES
Phase: NA • Sponsor: University Medical Center Goettingen • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Scientists track vision loss in rare genetic eye disease to pave way for future treatments
Knowledge-focused OngoingThis study follows 50 people with a rare inherited eye condition called PRPF31-related retinal dystrophy (RP11) to see how their vision changes over time. Researchers will measure things like visual acuity, retinal thickness, and quality of life using eye exams and questionnaires…
Matched conditions: RETINAL DYSTROPHIES
Sponsor: PYC Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC